Cite
HARVARD Citation
Lee, I. et al. (2023). A receptor-binding domain-based nanoparticle vaccine elicits durable neutralizing antibody responses against SARS-CoV-2 and variants of concern. Emerging microbes & infections. 12 (1), p. . [Online].